DuPont Showcases Cutting-Edge Interconnect Technologies to Advance AI and Next-Gen Electronics at JPCA Show 2025 DuPont a global innovation leader in materials and technology, proudly announces its participation in the upcoming Total Solution Exhibition for Electronic Equipment 2025, better known…
Marketing Authorization Application for Gadoquatrane Submitted in Japan Bayer has officially submitted a marketing authorization application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for gadoquatrane, its investigational gadolinium-based contrast agent designed for use in magnetic resonance imaging (MRI).…
Elinzanetant Demonstrates Significant Reduction in Hot Flashes for Breast Cancer Patients Undergoing Endocrine Therapy: Results from Phase III OASIS-4 Trial In a major advancement for women experiencing treatment-induced menopausal symptoms, detailed findings from the international Phase III OASIS-4 clinical study…
Enginzyme Appoints Aymeric de Gantès as CEO to Lead Next Phase of Growth; Founder Karim Engelmark Cassimjee to Serve as Chief Innovation Officer Enginzyme AB, a pioneering deep-tech company specializing in sustainable biomanufacturing through cell-free enzyme engineering, has announced a…
Succinic Acid Global Market for Active Ingredients in Cosmetics Set for Strong Growth Through 2030: Succinic Acid, Natural Extracts Drive Innovation Succinic Acid The global market for active ingredients used in cosmetic products is experiencing a robust growth phase, with…
Germany’s Shisha Market Set for Rapid Expansion as Hospitality Sector Embraces Innovation Market The hospitality sector in Germany is on the brink of a transformative shift as demand for shisha continues to climb at an unprecedented pace. According to new…
Bayer’s Sevabertinib (BAY 2927088) Receives FDA Priority Review for HER2-Mutant Non-Small Cell Lung Cancer FDA Bayer has announced that its investigational compound, sevabertinib (BAY 2927088), has been granted Priority Review status by the U.S. Food and Drug Administration (FDA) for…
Pimicotinib Shows Promising Phase 3 Results in Treating Tenosynovial Giant Cell Tumor (TGCT) Merck, a global leader in science and technology, has released detailed findings from Part 1 of its global Phase 3 MANEUVER trial. The study evaluated the investigational…
Wacker Biotech US and Expression Manufacturing Forge Strategic Alliance to Accelerate Lentiviral Vector Development for Next-Generation Gene Therapies Wacker Biotech In an era marked by rapid advancements in gene and cell therapies, the demand for high-quality, scalable lentiviral vectors has…
Team Sonnenwagen Unveils “Æthon” — Aiming for Victory in the World’s Toughest Solar Race Sonnenwagen In front of an enthusiastic audience of 800 guests gathered in their hometown of Aachen, Team Sonnenwagen proudly unveiled their latest solar-powered race car, “Æthon.”…
PhosAgro and FAO Launch RECSOIL Workshops on Soil Recarbonization PhosAgro, a leading Russian producer of phosphate-based fertilizers, in collaboration with the United Nations Food and Agriculture Organization (FAO), has initiated a series of scientific and practical workshops focusing on soil…
AskBio Publishes Full Phase 1b Results for AB-1005 Gene Therapy in Parkinson’s AskBio a pioneering gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has recently announced the full publication of the results from its…